The Teva/Johnson & Johnson pill is a combination antiviral drug that contains two nucleoside analogues (baloxavir marboxil and remdesivir). The drug was developed using synthetic chemistry technology to create two drugs that work together to inhibit the replication of the COVID 19 virus. It has been shown to be safe and effective in previous clinical trials and is currently being evaluated in a Phase III clinical trial.